Tonsilotren tablets, No. 60

• Acute angina (catarrhal, lacunar, follicular);

• chronic tonsillitis;

• to accelerate the healing of the pharyngeal mucosa after removal of the tonsils (in combination therapy).

In the acute course of the disease, children from 3 to 12 years old are prescribed 1 tab. every 2 hours for 1-2 days (no more than 8 times / day) until improvement occurs, then 1 tab. 3 times / day until complete recovery.

Adults and children over 12 years old are prescribed 1 tab. every hour for 1-2 days (no more than 12 times / day) until the onset of improvement, then - 1-2 tab. 3 times / day until complete recovery.

In chronic tonsillitis, children from 3 to 12 years old are prescribed 1 tab. 3 times / day, adults and children over 12 years old - 1-2 tab. 3 times / day for 6-8 weeks. It is recommended to carry out repeated courses of treatment (several times a year).

The tablets should be taken 30 minutes before or 30 minutes after a meal, slowly dissolving in the mouth. For children from 3 to 5 years old, tablets are given in crushed form under the tongue or dissolved in a small amount of liquid.

Lozenges

1 tab.

active substances:

Atropinum sulfuricum D5 12.5 mg

Hepar sulfuris D310 mg

Kalium bichromicum D 450 mg

Acidum silicicum (Silicea) D 25 mg

Hydrargirum biiodatum (Mercurius bijodatus) D825 mg

excipients: lactose monohydrate - 122.5 mg; sucrose - 24 mg; magnesium stearate - 1 mg

• Hypersensitivity to chromium or other components of the drug.

• It is not recommended to prescribe the drug to children under 3 years of age due to insufficient clinical data.

• The drug should be prescribed with caution in hyperthyroidism.

pharmachologic effect

Homeopathic medicine used for acute and chronic tonsillitis. The drug has an anti-inflammatory effect, stimulates regeneration processes, helps to reduce hypertrophied tonsils. Stimulates the immune system.

Side effect

Perhaps: increased salivation (in this case, you should reduce the dose or stop taking the drug).

Allergic reactions: in isolated cases - skin rash, skin itching (in this case, the drug should be discontinued).

Application during pregnancy and lactation

The use of the drug Tonsilotren during pregnancy and lactation (breastfeeding) is possible only if the intended benefit to the mother outweighs the potential risk to the fetus and child.

Application in children

It is not recommended to prescribe the drug to children under 3 years of age due to insufficient clinical data.

special instructions

When using Tonsilotren, a temporary worsening of the condition is possible. In this case, the patient should stop taking the drug and consult a doctor.

When using Tonsilotren, the use of other drugs is allowed.

The patient should be informed that in the absence of a therapeutic effect in an acute illness within the first 2 days, stop taking the drug and consult a doctor.

Overdose

Currently, no cases of overdose of the drug Tonsilotren have been reported.

Drug interactions

The drug interaction of the drug Tonsilotren with other drugs has not been established.